The global permethrin market is expected to be worth nearly USD 382 Million by 2032 from USD 201.7 Million in 2022, growing at a CAGR of 6.6% during the forecast period. Permethrin is a complex compound that is used as an insecticide toxin. The permethrin molecule is used in a variety of applications, including pharmaceuticals and agrochemicals. Permethrin is primarily used in agricultural applications as an insecticide.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2022) | USD 201.7 Million |
| Anticipated Forecast Value (2032) | USD 382 Million |
| Projected Growth Rate (2022 to 2032) | 6.6% CAGR |
Permethrin is used to protect crops from bees because it is a lethal pesticide for bees. Permethrin is also effective against other parasites. Permethrin is also used to control insects in the home. Permethrin is also used to protect woolen textiles from insect attack.
One of the most common pharmaceutical applications of permethrin in humans is the treatment of head lice. Permethrin cream or lotion is available for the treatment of scabies and head lice. Wheat, maize, cotton, and alfalfa are just a few of the crops that are protected by permethrin-based pesticides.
It is also used to keep mosquitos away. Permethrin is marketed under a variety of brand names, including Nix, Acticin, Elimite, Clearkin, DAT, Gzlthrin, and others. Permethrin's increasing use in various industries is expected to drive its demand during the forecast period.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Permethrin is highly toxic to a variety of parasites and acts as an insect repellent. Permethrin's properties are driving market demand for the substance. Permethrin's pharmaceutical applications, including its use to treat head lice, are expanding rapidly.
Increasing health awareness and a growing population is propelling the pharmaceutical industry forward, driving permethrin demand from pharmaceutical applications. The agricultural industry's growing demand for insecticides and pesticides is also driving permethrin demand. Permethrin's increasing household use is also driving up demand for it in a variety of household applications.
The pharmaceutical industry accounts for the majority of permethrin demand, while research and development are ongoing to discover new applications. Permethrin products with high concentrations are only available on prescription in the United States. As a result, research and development in this market is underway in search of improved products in combination with other substances.
Because permethrin is a highly toxic substance, it is only used in a few applications and in small amounts. Various regulations imposed by different countries' Food and Drug Administrations may act as a restraining factor for the permethrin market's robust growth during the forecast period.
The Asia Pacific, led by Australia, South Korea, Japan, China, and India, may see a significant increase in the permethrin market, accounting for more than 40% in the coming years. The emerging and densely populated regions, such as the Asia Pacific, have seen rapid growth.
The region's dense population can provide a favorable environment for the spread of head lice, driving demand for permethrin. Also, Asia Pacific's demand for permethrin is increasing due to the growing agricultural industry's demand for insecticides and pesticides.
India produces the most pulses, rice, wheat, spices, and spice products. Positive government actions, such as the National Food Security Mission (NFSM), which aims to increase rice, wheat, pulses, and coarse cereals, should drive agricultural pesticide demand, resulting in regional market growth.
Europe is the second most powerful region, owing to the region's growing pharmaceutical industries and high consumer health awareness. Countries such as France, the United Kingdom, Germany, and Italy drive the European market. Countries are focusing more on health-related research and development in order to develop and build a strong healthcare system. Furthermore, clinical trials and affirmative government initiatives to find solutions and treatments for unmet medical needs.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The pharmaceutical industry comes in second place in terms of application because it is widely used as a mosquito repellant to prevent mosquito-borne diseases such as dengue fever and malaria. Mosquito nets used to cover beds are treated with a Permethrin solution to kill mosquitos. Permethrin is effective for a longer period of time, such as several months, when used indoors.
Some of the important market players identified across the value chain of global permethrin market are:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.6% from 2022 to 2032 |
| Market Value in 2022 | USD 201.7 Million |
| Market Value in 2032 | USD 382 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Application, End user, Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Russia, BENELUX, Australia & New Zealand, China, Japan, South Korea, India, ASEAN, GCC, South Africa, Turkey |
| Key Companies Profiled | Biodyne-USA, LLC.; GlaxoSmithKline Plc.; Canixa Life Science; Delvin Formulations Pvt. Ltd.; Prestige Consumer Healthcare, Inc.; Loveland Products, Inc.; Geolife Organics Pvt. Ltd.; Wavelength Pharmaceuticals; Biophore; Harman Finochem Ltd.; Kalyani Industries Ltd. |
| Customization | Available Upon Request |
FMI projects the global Permethrin market to expand at a 6.6% value CAGR by 2032.
Asia is expected to be the most opportunistic Permethrin market
Biodyne-USA, LLC, GlaxoSmithKline plc. and Canixa Life Science are some prominent Permethrin manufacturers.
| Market Size (2023) | USD 271.8 million |
|---|---|
| Market Size (2033) | USD 422.2 million |
| Market CAGR (2023 to 2033) | 4.5% |
| Market Value (2022) | USD 274.12 million |
|---|---|
| Market Anticipated Value (2032) | USD 425.70 million |
| Projected CAGR (2022 to 2032) | 4.5% |
| Market Size (2022) | USD 6 Billion |
|---|---|
| Market Size (2032) | USD 11.6 Billion |
| Market CAGR (2022 to 2032) | 6.8% |
| Estimate Market Volume in 2021 | 653,843 tonnes |
|---|---|
| Projected Market Volume in 2027 | 871218 tonnes |
| CAGR during 2021 to 2027 | 4.90% |
Explore Fertilizer & Agrochemicals Insights
View Reports
Permethrin Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
